(Q46987545)

English

Respective clustering of unfavorable and favorable cytogenetic clones in myelofibrosis with myeloid metaplasia with homozygosity for JAK2(V617F) and response to erythropoietin therapy

scientific article published in April 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16532437

Respective clustering of unfavorable and favorable cytogenetic clones in myelofibrosis with myeloid metaplasia with homozygosity for JAK2(V617F) and response to erythropoietin therapy (English)

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16532437

1 reference

based on heuristic

inferred from title

myeloid metaplasia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

object named as

Ayalew Tefferi

1 reference

Europe PubMed Central

27 December 2017

author name string

Jacob J Strand

2

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16532437

Terra L Lasho

3

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16532437

Michelle A Elliott

4

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16532437

Chin-Yang Li

5

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16532437

Ruben A Mesa

6

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16532437

Gordon W Dewald

7

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16532437

language of work or name

0 references

publication date

1 April 2006

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16532437

number of pages

5

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16532437

106

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16532437

8

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16532437

1739-1743

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16532437

Myelofibrosis with myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21787

7 January 2021

based on heuristic

inferred from DOI database lookup

Der(6)t(1;6)(q21-23;p21.3): a specific cytogenetic abnormality in myelofibrosis with myeloid metaplasia.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21787

7 January 2021

based on heuristic

inferred from DOI database lookup

Gains on 9p are common genomic aberrations in idiopathic myelofibrosis: a comparative genomic hybridization study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21787

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of aberrant gene expression in CD34+ hematopoietic stem cells from patients with agnogenic myeloid metaplasia using oligonucleotide microarrays

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21787

7 January 2021

based on heuristic

inferred from DOI database lookup

RARbeta2 is a candidate tumor suppressor gene in myelofibrosis with myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21787

7 January 2021

based on heuristic

inferred from DOI database lookup

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21787

7 January 2021

based on heuristic

inferred from DOI database lookup

The JAK2(V617F) tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21787

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21787

7 January 2021

based on heuristic

inferred from DOI database lookup

Chromosome 7 deletions are associated with unfavorable prognosis in myelofibrosis with myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21787

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic diversity among cytogenetic abnormalities in myelofibrosis with myeloid metaplasia.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21787

7 January 2021

based on heuristic

inferred from DOI database lookup

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21787

7 January 2021

based on heuristic

inferred from DOI database lookup

JAK2 mutations in myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21787

7 January 2021

based on heuristic

inferred from DOI database lookup

Modern management of myelofibrosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21787

7 January 2021

based on heuristic

inferred from DOI database lookup

Erythropoietin treatment of the anaemia of myelofibrosis with myeloid metaplasia: results in 20 patients and review of the literature.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21787

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of the androgen response of 23 patients with agnogenic myeloid metaplasia: the value of chromosomal studies in predicting response and survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21787

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and tolerability of danazol as a treatment for the anaemia of myelofibrosis with myeloid metaplasia: long-term results in 30 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21787

7 January 2021

based on heuristic

inferred from DOI database lookup

Durable responses to thalidomide-based drug therapy for myelofibrosis with myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21787

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.21787

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16532437

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/16532437

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46987545&oldid=2140954325"